NCT04704713View on ClinicalTrials.gov

Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 5, 2010

Primary Completion Date

December 9, 2010

Conditions
Polymorphic Light Eruption
Interventions
DRUG

Afamelanotide

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Clinuvel Pharmaceuticals Limited

INDUSTRY